New Delhi: The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous COVID-19 vaccine for COVID-19. They will use the virus strain isolated at ICMR’s National Institute of Virology (NIV), Pune, said an official notification.
The strain has been successfully transferred from NIV to BBIL. Work on vaccine
development has been initiated between the two partners. ICMR-NIV will
provide continuous support to BBIL for vaccine development. ICMR and BBIL
will seek fast-track approvals to expedite vaccine development, subsequent
animal studies and clinical evaluation of the candidate vaccine.
Dubai: ODI cricket, Pakistan – they bring out the best in Virat Kohli. The Dubai… Read More
Cuttack: Three criminals were arrested by Choudwar police in Odisha’s Cuttack district for allegedly looting… Read More
Kolkata: Odisha FC fought gallantly in the lion’s den but finally returned empty-handed. Up against league… Read More
Kolkata: A West Bengal secondary board exam (Madhyamik) candidate recently took Artificial Intelligence (AI) to… Read More
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
This website uses cookies.
